Far­ru­gia named CEO at Mayo Clinic Florida

Modern Healthcare - - NEWS MAKERS -

Who: Dr. Gian­rico Far­ru­gia, 50

Cur­rent roles: Direc­tor of the Mayo Clinic Cen­ter for In­di­vid­u­al­ized Medicine in Rochester, Minn., and a pro­fes­sor of medicine, phys­i­ol­ogy and bio­med­i­cal engi­neer­ing at Mayo’s med­i­cal school. “We now can quickly de­code ev­ery let­ter in a pa­tient’s genes and their whole genome,” he said on the cen­ter’s web­site. “This in­for­ma­tion opens re­mark­able op­por­tu­ni­ties in our abil­ity to in­di­vid­u­al­ize the way we pre­vent, pre­dict, di­ag­nose and treat dis­eases.”

New po­si­tion: Pres­i­dent and CEO of Mayo Clinic’s Jack­sonville, Fla., cam­pus, ef­fec­tive Jan. 1. The 214-bed Mayo Clinic Florida opened in 2008.

Mayo Clinic CEO’s take: “Dr. Far­ru­gia brings a wealth of ex­pe­ri­ence to his new role,” Mayo CEO Dr. John Nose­wor­thy said. “He is a physi­cian leader who brings to this im­por­tant role a deep com­mit­ment to Mayo’s val­ues, mis­sion and strate­gic vi­sion, along with a pas­sion to lead and equip teams to reach more pa­tients and strengthen Mayo Clinic’s po­si­tion as a global health­care leader.”

His med­i­cal back­ground: Far­ru­gia is a gas­troen­terol­o­gist and a direc­tor of Mayo’s En­teric Neu­ro­science Pro­gram, which stud­ies the gas­troin­testi­nal tract’s neu­ro­mus­cu­lar sys­tem. The goal of the pro­gram is to de­velop med­i­cal and sur­gi­cal ther­a­pies for pa­tients who suf­fer from in­testi­nal motil­ity disor­ders, such as ir­ri­ta­ble bowel syn­drome.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.